IL22RA1
Interleukin-22 receptor subunit alpha-1
Also known as: CRF2-9, I22R1_HUMAN, IL22R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N6P7
- Gene
- IL22RA1
- Ensembl
- ENSG00000142677
- Chromosome
- 1
- Canonical length
- 574 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene belongs to the class II cytokine receptor family, and has been shown to be a receptor for interleukin 22 (IL22). IL22 receptor is a protein complex that consists of this protein and interleukin 10 receptor, beta (IL10BR/CRFB4), a subunit also shared by the receptor complex for interleukin 10 (IL10). This gene and interleukin 28 receptor, alpha (IL28RA) form a cytokine receptor gene cluster in the chromosomal region 1p36. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
574 residues, UniProt reviewed canonical sequence.
>Q8N6P7|IL22RA1
1 MRTLLTILTV GSLAAHAPED PSDLLQHVKF QSSNFENILT WDSGPEGTPD TVYSIEYKTY
61 GERDWVAKKG CQRITRKSCN LTVETGNLTE LYYARVTAVS AGGRSATKMT DRFSSLQHTT
121 LKPPDVTCIS KVRSIQMIVH PTPTPIRAGD GHRLTLEDIF HDLFYHLELQ VNRTYQMHLG
181 GKQREYEFFG LTPDTEFLGT IMICVPTWAK ESAPYMCRVK TLPDRTWTYS FSGAFLFSMG
241 FLVAVLCYLS YRYVTKPPAP PNSLNVQRVL TFQPLRFIQE HVLIPVFDLS GPSSLAQPVQ
301 YSQIRVSGPR EPAGAPQRHS LSEITYLGQP DISILQPSNV PPPQILSPLS YAPNAAPEVG
361 PPSYAPQVTP EAQFPFYAPQ AISKVQPSSY APQATPDSWP PSYGVCMEGS GKDSPTGTLS
421 SPKHLRPKGQ LQKEPPAGSC MLGGLSLQEV TSLAMEESQE AKSLHQPLGI CTDRTSDPNV
481 LHSGEEGTPQ YLKGQLPLLS SVQIEGHPMS LPLQPPSRPC SPSDQGPSPW GLLESLVCPK
541 DEAKSPAPET SDLEQPTELD SLFRGLALTV QWESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL22RA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 189 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 189 nTPM
- skin: 38 nTPM
- small intestine: 27 nTPM
- duodenum: 19 nTPM
- esophagus: 17 nTPM
- colon: 11 nTPM
Single-cell type
- pancreatic acinar cells: 183 nCPM
- esophageal apical cells: 117 nCPM
- enterocytes: 93 nCPM
- paneth cells: 58 nCPM
- colonocytes: 32 nCPM
- goblet cells: 24 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 1 nTPM
- cerebral cortex: 0.7 nTPM
- cerebellum: 0.6 nTPM
- medulla oblongata: 0.3 nTPM
- hypothalamus: 0.2 nTPM
- spinal cord: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytokine-mediated signaling pathway
- defense response to Gram-negative bacterium
- negative regulation of cytokine production involved in inflammatory response
- negative regulation of inflammatory response
Molecular functions
- cytokine receptor activity
- interleukin-20 binding
- interleukin-22 receptor activity
- interferon receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL22RA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL22RA1 as an antibody target. Whether an autoantibody or antibody against IL22RA1 could matter depends on whether native IL22RA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL22RA1 is annotated at the cell surface, where native IL22RA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL22RA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...